Funded Research

Research Award Program
Cutaneous Lymphoma Catalyst Research Grant

In August of 2019 the the Cutaneous Lymphoma Foundation's Research Advisory Council, with support from the Leukemia & Lymphoma Society (LLS), launched the all new Cutaneous Lymphoma Catalyst Research Grant. The Catalyst grant will provide researchers with the funding needed to continue and/or complete their work being done in cutaneous lymphoma. This short-term research program will span two years and award two (or more depending on funding) $50,000 grants per year.

Read more

Cutaneous Lymphoma Catalyst Research Grant Recipients

Patrizia Fuschiotti, PhD, University of Pittsburgh

Michael Girardi, MD, Yale University School of Medicine

Ali Jabbari, MD, PhD, University of Iowa Carver College of Medicine

Xiaolong Zhou, MD, MSc, Northwestern University Feinberg School of Medicine


In March 2012, the Cutaneous Lymphoma Foundation’s Board of Directors approved a new Research Awards Program (RAP), the first dedicated exclusively to funding cutaneous lymphoma research. The signature funding initiative of the RAP, was the CLARIONS Grant Program, which stands for Curing Cutaneous Lymphoma by Advancing Research, Innovation and Offering New Solutions. This research grant program supported investigators interested in conducting innovative cutaneous lymphoma research.

Read More

CLARIONS Grant Recipients

Leandro Cerchietti, MD, Weill Cornell Medical College

Rachael Clark, MD, PhD, Brigham and Women's Hospital

Patrizia Fuschiotti, PhD, University of Pittsburgh

Sergei Koralov, PhD, New York University School of Medicine

Tae Jin Kim, PhD, Stanford University School of Medicine

John O'Malley, MD, PhD, Brigham and Women's Hospital

Delphine Rolland, PharmD, PhD, University of Pennsylvania

Stefan M. Schieke, MD, Medical College of Wisconsin

Learn more about CLARIONS recipients research in our annual Research Reports.

Other Supported Research

Research Discovers CTCL Incidence Rising in United States

The Cutaneous Lymphoma Foundation funded an important epidemiology study that shows that the number of new cases of CTCL has doubled. In this study, Drs. Vincent Criscione and Martin Weinstock of Brown University report that there are approximately 1,600 new cases of CTCL diagnosed each year in the United States. This represents over double the number of new cases in the past fifteen years.

Read more

Groundbreaking Quality of Life Research Study

Dr. Marie-France Demierre of Boston University School of Medicine, Director of Skin Oncology, collaborated with the Cutaneous Lymphoma Foundation on an extremely important study, that of our patients’ health-related quality of life. Health-related quality of life is a multidimensional term that includes the physical, functional, psychological, social health, and well-being of the individual.

Read more

Epidemiology Characterization Synonyms CTCL

BACKGROUND: The familial occurrence of mycosis fungoides (MF) has been reported only in 8 families. Recently, the HLA class II alleles DRB1* 11 and DQB1* 03 have been found to be significantly increased for patients with sporadic MF, suggesting a possible immunogenetic basis for the pathogenesis of this malignancy.
OBJECTIVE: We sought to detect familial occurrences of MF, to describe familial features, and to investigate the possible association or linkage with the HLA system in such cases.

Read more

Learn More

Research Awards Program

In recent years, more attention, funding and science has been devoted to cutaneous lymphoma research than ever before. The Cutaneous Lymphoma Foundation has been a strong partner to researchers who are a driving force behind this change.
Sign up for our newsletter and stay up to date on any research developments.
CLF provides free publications filled with helpful information.
We thank each person who helps us make sure each person with cutaneous lymphoma gets the best care possible.